Wellington Management Group LLP Alkermes Plc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Alkermes Plc. stock. As of the latest transaction made, Wellington Management Group LLP holds 12,658,245 shares of ALKS stock, worth $357 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,658,245

Previous 14,354,752 11.82%

Holding current value

$357 Million

Previous $346 Million 2.42%

% of portfolio

0.06%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $39 Million - $48.4 Million	-1,696,507 Reduced 11.82%	12,658,245 $354 Million
Q2 2024 Aug 13, 2024	SELL	$23.21 - $27.24 $12.5 Million - $14.6 Million	-537,608 Reduced 3.61%	14,354,752 $346 Million
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $393 Million - $485 Million	14,892,360 New	14,892,360 $403 Million
Q4 2023 Feb 12, 2024	BUY	$23.37 - $28.68 $356 Million - $437 Million	15,241,470 New	15,241,470 $423 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $110 Million - $130 Million	4,055,926 Added 52.74%	11,746,792 $329 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $27.8 Million - $33 Million	980,531 Added 14.61%	7,690,866 $241 Million
Q1 2023 May 12, 2023	BUY	$25.31 - $29.02 $16.9 Million - $19.3 Million	665,957 Added 11.02%	6,710,335 $189 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $14.9 Million - $17.8 Million	-678,027 Reduced 10.09%	6,044,378 $158 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $16.9 Million - $24.5 Million	767,373 Added 12.89%	6,722,405 $150 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $146 Million - $169 Million	-5,524,509 Reduced 48.12%	5,955,032 $177 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $7.58 Million - $9.2 Million	-328,681 Reduced 2.78%	11,479,541 $302 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $56.6 Million - $77.9 Million	-2,423,415 Reduced 17.03%	11,808,222 $364 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $118 Million - $158 Million	-6,295,792 Reduced 30.67%	14,231,637 $349 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $190,658 - $242,904	-10,470 Reduced 0.05%	20,527,429 $383 Million
Q4 2020 Feb 12, 2021	SELL	$15.39 - $22.1 $21.7 Million - $31.2 Million	-1,411,593 Reduced 6.43%	20,537,899 $410 Million
Q3 2020 Nov 16, 2020	BUY	$16.16 - $20.66 $416,265 - $532,180	25,759 Added 0.12%	21,949,492 $364 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $19.41 $117,780 - $171,759	-8,849 Reduced 0.04%	21,923,733 $425 Million
Q1 2020 May 14, 2020	BUY	$13.06 - $21.24 $1.36 Million - $2.21 Million	103,826 Added 0.48%	21,932,582 $316 Million
Q4 2019 Feb 11, 2020	BUY	$17.29 - $21.74 $377 Million - $475 Million	21,828,756 New	21,828,756 $445 Million

Others Institutions Holding ALKS

# of Institutions

360

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.63B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Alkermes Plc. Transaction History